Circadian regulation of liver metabolism: experimental approaches in human, rodent, and cellular models.

circadian glucose lipids misalignment shift work

Journal

American journal of physiology. Cell physiology
ISSN: 1522-1563
Titre abrégé: Am J Physiol Cell Physiol
Pays: United States
ID NLM: 100901225

Informations de publication

Date de publication:
01 Nov 2023
Historique:
pubmed: 29 8 2023
medline: 29 8 2023
entrez: 29 8 2023
Statut: ppublish

Résumé

Circadian rhythms are endogenous oscillations with approximately a 24-h period that allow organisms to anticipate the change between day and night. Disruptions that desynchronize or misalign circadian rhythms are associated with an increased risk of cardiometabolic disease. This review focuses on the liver circadian clock as relevant to the risk of developing metabolic diseases including nonalcoholic fatty liver disease (NAFLD), insulin resistance, and type 2 diabetes (T2D). Many liver functions exhibit rhythmicity. Approximately 40% of the hepatic transcriptome exhibits 24-h rhythms, along with rhythms in protein levels, posttranslational modification, and various metabolites. The liver circadian clock is critical for maintaining glucose and lipid homeostasis. Most of the attention in the metabolic field has been directed toward diet, exercise, and rather little to modifiable risks due to circadian misalignment or disruption. Therefore, the aim of this review is to systematically analyze the various approaches that study liver circadian pathways, targeting metabolic liver diseases, such as diabetes, nonalcoholic fatty liver disease, using human, rodent, and cell biology models.

Identifiants

pubmed: 37642240
doi: 10.1152/ajpcell.00551.2022
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

C1158-C1177

Subventions

Organisme : Novo Nordisk (Novo Nordisk Global)
Organisme : British Heart Foundation (BHF)
Organisme : Wellcome Trust (WT)

Auteurs

Lorna J Daniels (LJ)

Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.

Danielle Kay (D)

Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.

Thomas Marjot (T)

Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.

Leanne Hodson (L)

Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
NIHR Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, United Kingdom.

David W Ray (DW)

Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
NIHR Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, United Kingdom.
Kavli Centre for Nanoscience Discovery, University of Oxford, Oxford, United Kingdom.

Classifications MeSH